Cystatin-C C-guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project

Clinical trial NCT02945241 · COMPLETED

Trial details

NCT number: NCT02945241
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Methicillin-resistant Staphylococcus Aureus Sepsis Critical Illness

Start date: 2014-04-01
Primary completion: 2015-06-01
Enrollment: 399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.